goodrx novo nordisk - Search News

News

Novo Nordisk slashes price of Ozempic

Fast Company on MSN · 2d

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk’s breakup with Hims

GoodRx will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss medications.

The Pharma Letter · 1d

GoodRx and Novo Nordisk unveil $499 monthly offer for Ozempic and Wegovy

GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy (semaglutide) available to eligible self-paying patients for $499 per month.

Fortune on MSN · 2d

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

Who benefits? The reduced price applies to self-paying patients—those without insurance, or whose insurance doesn’t cover Ozempic. More than 70,000 U.S. pharmacies are participating through partnerships with GoodRx and NovoCare, Novo Nordisk’s cash-pay pharmacy.

2don MSN

Why Novo Nordisk Stock Popped Monday

Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...

2d

Stock Movers: Novo Nordisk, GoodRX, CVS

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

1d

GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On?

GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results